95253 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
Pyrrolidine derivatives and their use as complement pathway modulators
#3302Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
#3303NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
#3304Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer
#3305Benzimidazole-proline derivatives
#3306Modulators of calcium release-activated calcium channel
#3307Inhibitors of HCV NS5A
#3308Heterocyclyl pyrimidine analogues as TYK2 inhibitors
#3309Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors
#33101-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
#3311Compound and organic light-emitting device comprising the compound
#3312Additives for electroplating baths
#3313ANTI-VIRAL COMPOUNDS
#3314Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
#3315PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
#3316Tropomyosin-related kinase (TRK) inhibitors
#3317Heterocyclic compounds useful for kinase inhibition
#33182,4-Pyrimidinediamine compounds and their uses
#3319Compound and photoacoustic imaging contrast medium containing the compound
#3320Pyridinone and pyrimidinone derivatives as factor Xia
#3321COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
#3322SecA inhibitors and methods of making and using thereof
#3323N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer
#3324Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases
#3325Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
#3326Complement pathway modulators and uses thereof
#3327Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
#3328Complement pathway modulators and uses thereof
#3329Solid forms of an antiviral compound
#3330Carbohydrate-selective receptors
#3331Pyrimidine pyrazolyl derivatives
#3332Graphene nanodispersion and method for preparing same
#3333Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones
#3334NOVEL ORGANIC ELECTROLUMINESCENCE COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME
#3335Ring-substituted N-pyridinyl amides as kinase inhibitors
#3336Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase
#3337Heterocyclic compound
#33384-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use
#3339NOVEL ORGANIC ELECTROLUMINESCENCE COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME
#3340Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#3341Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives
#3342Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
#3343Modulators of TNF-α signaling
#3344Piperazinyl pyrimidine derivatives, preparation method and use thereof
#3345Triazole compounds that modulate HSP90 activity
#3346Complement pathway modulators and uses thereof
#3347Pyridazine derivatives as RORc modulators
#3348Molecular probes for multimodality imaging and tracking of stem cells
#3349Inhibitors of the fibroblast growth factor receptor
#3350Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative
#3351PROCESS OF PREPARATION OF AZIMSULFURON
#3352Small compounds targeting TACC3
#3353Compositions useful for treating disorders related to KIT
#3354Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
#3355Heterocyclic compounds and uses thereof
#3356NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
#3357Compositions useful for treating disorders related to kit
#3358Intermediates to prepare herbicidal pyrimidone derivatives
#3359METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#3360Selectively substituted quinoline compounds
#3361Pyrazolyl quinoxaline kinase inhibitors
#3362Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
#3363ROR modulators and their uses
#3364Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
#3365Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by LP-PLA2
#3366Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin Dmediated diseases
#3367IMIDAZOLIN-5-ONE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCER
#3368Tetrazines and method of synthezising the same
#3369Inhibitors of protein kinases
#3370Heterocyclic compound
#3371COMPOUNDS AND METHODS FOR TREATING MALARIA
#3372Process for the preparation of vilazodone hydrochloride and its amorphous form
#3373Method for the preparation of triazole compounds
#3374Substituted aminopyrimidine compounds and methods of use
#3375Substituted aminopyrimidine compounds and methods of use
#3376Therapeutic piperazines
#3377Anti-viral compounds
#3378Substituted pyrazole-containing compounds and their use as pesticides
#3379Polymerizable monomer, and material for organic device, hole injection/transport material, material for organic electroluminescence element and organic electroluminescent element each comprising polymer (polymeric compound) of the polymerizable monomer
#3380Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
#3381Carbamate compounds and of making and using same
#3382Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
#3383Radiolabeled prostate specific membrane antigen inhibitors
#3384Organic electroluminescent element, organic electroluminescent lighting device and organic electroluminescent display device
#3385Pesticidal arylpyrrolidines
#33861, 2, 4-triazole derivatives and their anti-microbial activity
#3387Oligooxopiperazines and methods of making and using them
#3388Substituted triazoles useful as Axl inhibitors
#3389Inhibitors of hepatitic C virus
#3390ANTI-VIRAL COMPOUNDS
#3391Substituted indazole derivatives active as kinase inhibitors
#3392Pyrimidinone carboxamide inhibitors of endothelial lipase
#3393SURVIVAL BENEFIT IN PATIENTS WITH SOLID TUMORS WITH ELEVATED C-REACTIVE PROTEIN LEVELS
#3394Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof
#3395Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device
#3396Organic electroluminescent element and material for organic electroluminescent elements
#3397Nonpolar phase-soluble metathesis catalysts
#33986-Alkynyl Pyridine
#3399Substituted indazole derivatives active as kinase inhibitors
#3400Substituted indazole derivatives active as kinase inhibitors
#3401Bis-amido pyridines
#3402Benzyl substituted triazine derivatives and their therapeutical applications
#3403ALKYNYL ALCOHOLS AND METHODS OF USE
#3404INHIBITORS OF HCV NS5A
#3405Organic electroluminescent materials and devices
#3406Pyrazole aminopyrimidine derivatives as LRRK2 modulators
#3407Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
#3408TRIAZOLE DERIVATIVES AS HSP90 INHIBITORS
#3409Inhibitors of c-fms kinase
#3410Substituted pyrazines as ATR kinase inhibitors
#3411Nitrogen-containing heterocyclic compound or salt thereof
#3412Compound, light-emitting material, and organic light-emitting device
#3413Cinnoline derivatives
#3414INHIBITORS OF HCV NS5A
#3415Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
#34166,5-Heterocyclic Propargylic Alcohol Compounds and Uses Therefor
#3417Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode
#3418ANTI-VIRAL COMPOUNDS
#3419s-Triazine compounds, pharmaceutical compositions and methods of using the same
#3420Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
#3421Cyclic amides as MetAP-2 inhibitors
#3422Substituted pyrazin-2-amines as inhibitors of ATR kinase
#3423Hepatitis C Virus Inhibitors
#3424PYRIMIDIN-4-YL)OXY)-1H-INDOLE-1-CARBOXAMIDE DERIVATIVES AND USE THEREOF
#3425Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics
#3426Benzimidazole derivatives as MCH receptor antagonists
#3427Inhibitors of leukotriene production
#3428Nuclear transport modulators and uses thereof
#34295-substituted benzimidazolium compounds
#3430Hepatitis C virus inhibitors
#3431Triazine compounds as PI3 kinase and MTOR inhibitors
#3432Methods and compositions for modulating Ire1, SRC and ABL activity
#3433Pesticidal arylpyrrolidines
#3434Protein kinase inhibitors
#3435Pyridazinone derivatives
#3436Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same
#3437Pathway analysis for identification of diagnostic tests
#34382,4-pyrimidinediamine compounds and their uses
#3439Azaheterocyclic compounds
#34405-membered heterocyclic amides and related compounds
#3441PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS KINASE INHIBITORS
#3442Primary carboxamides as BTK inhibitors
#3443Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative
#3444Organic compound and organic electroluminescent device employing the same
#34454-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof
#3446Substituted quinazolinones as HCV inhibitors
#34475-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
#3448Phthalazinone derivatives
#3449SUBSTITUTED BIPHENYLENE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
#3450Chemical compounds
#3451Inhibitors of hepatitis C virus replication
#3452ANTI-VIRAL COMPOUNDS
#3453ANTI-VIRAL COMPOUNDS
#3454COMPOUND SUITABLE FOR THE TREATMENT OF SYNUCLEOPATHIES
#3455Immunoconjugates, compositions for making them, and methods of making and use
#3456Quinoline and cinnoline derivatives and their applications
#3457Antiviral compounds highly effective as HCV-NS5A inhibitor
#3458Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
#3459Heterocyclic compound and organic light-emitting device comprising the same
#3460Pyrazol-3-ones that activate pro-apoptotic BAX
#3461Chemical compounds
#3462Hetero-bicyclic derivatives as HCV inhibitors
#3463Organic compounds and their uses
#3464Material for organic electroluminescent element and organic electroluminescent element using same
#3465Aryl-amine derivative and organic electroluminescent device using the same as a hole transport material
#3466Potent and selective inhibitors of hepatitis C virus
#3467PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#3468Metalloenzyme inhibitor compounds
#34694,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof
#3470ANTI-VIRAL COMPOUNDS
#3471Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
#3472Hepatitis C inhibitor compounds
#34735-substituted indazoles as kinase inhibitors
#34741,2,4-triazine-6-carboxamide derivative
#3475Bipyrazole derivatives as JAK inhibitors
#3476Anti-depression compounds
#3477Benzimidazole derivatives
#3478Organic light-emitting device, and delayed fluorescent material and compound used therefor
#3479Process and intermediates for the production of CCR2 antagonists
#3480Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amide
#3481Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors
#3482-indazoles as EPreceptor antagonists
#3483Monoamine compound, charge transport material, composition for charge transport film, organic electroluminescent element, organic EL display, and organic EL lighting
#34842,4-pyrimidinediamine compounds and their uses
#3485Dimeric IAP inhibitors
#3486Insecticidal triazinone derivatives
#3487Substituted cyclopropyl compounds useful as GPR119 agonists
#3488Biheteroaryl compounds and uses thereof
#3489Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
#3490HCV protease inhibitors and uses thereof
#3491Pyrazinecarboxamide compound
#3492Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#3493sGC STIMULATORS
#3494SELECTIVE KINASE INHIBITORS
#3495Processes for the preparation of novel benzimidazole derivatives
#3496Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof
#3497Aminopyrazole derivative
#3498Anti-viral compounds
#3499Biscarbazole derivatives and organic electroluminescence device employing the same
#3500Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
#3501Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
#35024-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors
#3503INDAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
#3504Pyrazine kinase inhibitors
#3505Organic electroluminescence element, and material for organic electroluminescence element
#3506THERAPEUTIC COMPOUNDS
#35072,4-pyridinediamine compounds and their uses
#3508Halogenated compounds for photodynamic therapy
#3509Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#3510Halogenated compounds for photodynamic therapy
#3511Compositions useful for treating disorders related to kit
#3512Heterocyclic compound and organic light-emitting device including the same
#3513TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
#3514Heterocyclic substituted pyrimidine compound
#3515Modulators of opioid receptors and methods of use thereof
#3516Heterocyclic compounds and uses thereof
#3517Articles and methods comprising persistent carbenes and related compositions
#3518CDC7 inhibitors
#3519Substituted 2-azabicycles and their use as orexin receptor modulators
#3520Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
#3521Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
#3522Uracil derivatives as AXL and c-MET kinase inhibitors
#3523Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative
#3524Heterocyclic derivative having PGD2 receptor antagonist activity
#3525DNA-PK inhibitors
#35261,2,6-substituted benzimidazoles as FLAP modulators
#3527Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C
#3528Substituted quinoxaline DNA-PK inhibitors
#3529Pyridinyl and fused pyridinyl triazolone derivatives
#3530Benzoimidazoles as prolyl hydroxylase inhibitors
#35311,3 substituted azetidine PDE10 inhibitors
#3532Heteroaryl sodium channel inhibitors
#3533AMINOPYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
#3534Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
#3535Triazine based radiopharmaceuticals and radioimaging agents
#3536Bicyclic heterocyclic compound
#3537Pyrimidine compounds as tuberculosis inhibitors
#3538PIM KINASE INHIBITORS AND METHODS OF THEIR USE
#3539Triazolyl PDE10 inhibitors
#3540Antiviral compounds
#3541Halogenated compounds for Photodynamic therapy
#3542Azetidinyl diamides as monoacylglycerol lipase inhibitors
#3543Material for organic electroluminescent element, and organic electroluminescent element produced using same
#3544Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative
#3545Method of treatment or prophylaxis
#3546Bis-indolic derivatives, their uses in particular as antibacterials
#3547Substituted indazole derivatives active as kinase inhibitors
#3548Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors
#3549Compounds for electronic devices
#3550RAF KINASE INHIBITORS
#3551Heterocyclic compounds as pesticides
#3552Therapeutic compounds
#3553THERAPEUTIC COMPOUNDS
#3554COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES
#3555Flap modulators
#3556NEW TRIAZINE DERIVATIVE AND ULTRAVIOLET ABSORBER
#3557UNSATURATED NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS
#35581,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
#3559Inhibitors of poly(ADP-ribose)polymerase
#3560Antioxidant small molecules aimed at targeting metal-based oxidative stress in neurogenerative disorders
#3561Five-membered heterocycles useful as serine protease inhibitors
#3562Substituted 4-(1H-pyrazol-4-yl)benzyl analogues as positive allosteric modulators of mAChR Mreceptors
#3563Heterocycle amido alkyloxy substituted quinazoline derivative and use thereof
#3564Hepatitis C Virus Inhibitors
#3565DENDRON REPORTER MOLECULES
#3566Anti-malarial compounds from marine natural products
#3567Inhibitors for steroid response elements and RNA polymerase II and related methods
#3568Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#3569Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#3570Antiplatelet agent
#3571Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
#3572NOVEL BENZIMIDAZOLE DERIVATIVES
#3573AMINOPYRIDINES AND AMINOPYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
#3574PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS
#3575Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
#3576Compounds and methods of use thereof for treating neurodegenerative disorders
#3577Oxygen-containing fused ring amine compound, sulfur-containing fused ring amine compound and organic electroluminescence device
#3578Rho kinase inhibitors and methods of use
#3579Phosphatidylinositol 3-kinase inhibitors
#3580Uracil derivative and use thereof for medical purposes
#3581Fused pyrimidine compounds and use thereof
#3582Aryl and heteroaryl fused lactams
#3583Bicyclic heterocycle compounds and their uses in therapy
#3584Heterocyclyl Pyrimidine Analogues As JAK Inhibitors
#3585Pharmaceutically active disubstituted triazine derivatives
#3586Ectoparasiticidal active substance combinations
#3587Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals
#3588Dental restorative materials based on polymerizable azides and alkynes
#3589Chemica compounds
#3590AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE
#3591Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
#3592Diazole lactams
#3593Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
#3594Bipolar hosts for light emitting devices
#3595PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#3596PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#3597Phosphonoxy quinazoline derivatives and their pharmaceutical use
#3598Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
#3599Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
#3600Compound for organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode